Lung cancer study tracks Real-World care in china

NCT ID NCT05872763

Completed Knowledge-focused Sponsor: Hoffmann-La Roche Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Aug 14, 2026 · Updated 3 times

Summary

This study follows 1,200 people in China newly diagnosed with advanced non-small-cell lung cancer (stage IIIB/IV) that cannot be removed by surgery. Researchers will collect information from medical records and follow patients over time to see what treatments they receive, how long they live, and what genetic markers their tumors have. The goal is to understand real-world medical practice and the economic burden on patients, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARCINOMA, NON-SMALL-CELL LUNG

Contacts and locations

Locations

Beijing Chest Hospital

Beijing, 101149, China
Cancer Hospital Chinese Academy of Medical Sciences.

Beijing, 100021, China
First Affiliated Hospital of Medical College of Xi'an Jiaotong University

Xi'an, 710061, China
Guangxi Cancer Hospital of Guangxi Medical University

Nanning, 530021, China
Harbin Medical University Cancer Hospital

Harbin, 150081, China
Hubei Cancer Hospital

Wuhan, 430079, China
Jiangsu Province Hospital (the First Affiliated Hospital With Nanjing Medical University)

Nanjing, 210029, China
Shandong Cancer Hospital

Jinan, 250117, China
Shanxi Province Cancer Hospital

Taiyuan, 030013, China
Sichuan Provincial Cancer Hospital

Chengdu, 610041, China
The First Affiliated Hospital of Zhengzhou University

Zhengzhou, 450052, China
The Fourth Hospital of Hebei Medical University

Shijiazhuang, 050000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.